Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about AKT2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Gene Symbol | AKT2 |
| Full Name | AKT Serine/Threonine Kinase 2 |
| Chromosome | 19q13.2 |
| Protein Type | Kinase |
| Function | is a crucial signaling molecule in the PI3K/AKT signaling pathway that plays essential roles in cell survival, metabolism, and neuronal function. |
| Primary Expression | Brain (widespread), Muscle, Liver, Adipose tissue |
| Exons | 13 |
| Pathways | Akt, Apoptosis, Autophagy, Immune Response, Mitophagy |
| UniProt ID | P31751 |
| NCBI Gene ID | 207 |
| Ensembl ID | ENSG00000105221 |
| OMIM | 164731 |
| GeneCards | AKT2 |
| Human Protein Atlas | AKT2 |
| Associated Diseases | Aging, Als, Atherosclerosis, Cancer, Cardiovascular |
| Interactions | ALZHEIMER, ALZHEIMER'S DISEASE, AND, APOPTOSIS, APP, APP/PS1 |
| KG Connections | 97 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
AKT2["AKT2"] -->|"modulates"| Lysosomal_Synapse_Formation["Lysosomal Synapse Formation"]
style Lysosomal_Synapse_Formation fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
AKT2["AKT2"] -->|"modulates"| Lysosomal_Synapses["Lysosomal Synapses"]
style Lysosomal_Synapses fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
AKT2["AKT2"] -->|"regulates"| Als["Als"]
style Als fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
AKT2["AKT2"] -->|"regulates"| Ms["Ms"]
style Ms fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
AKT2["AKT2"] -->|"associated"| Aging["Aging"]
style Aging fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
AKT2["AKT2"] -->|"implicated in"| Cancer["Cancer"]
style Cancer fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
AKT2["AKT2"] -->|"implicated in"| Atherosclerosis["Atherosclerosis"]
style Atherosclerosis fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
AKT3["AKT3"] -->|"associated"| AKT2["AKT2"]
style AKT3 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
AKT["AKT"] -->|"associated"| AKT2["AKT2"]
style AKT fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
PI3K["PI3K"] -->|"regulates"| AKT2["AKT2"]
style PI3K fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
MTOR["MTOR"] -->|"regulates"| AKT2["AKT2"]
style MTOR fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
MIRNAS["MIRNAS"] -->|"regulates"| AKT2["AKT2"]
style MIRNAS fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
style AKT2 fill:#006494,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold| Target | Relation | Type | Str |
|---|---|---|---|
| Lysosomal Synapse Formation | modulates | process | 0.95 |
| Glucose Metabolism | regulates | process | 0.90 |
| glucose uptake | promotes | process | 0.88 |
| Lysosomal Synapses | modulates | process | 0.85 |
| Hepatic Glycogen Synthesis | involved_in | process | 0.85 |
| Atherosclerosis | implicated_in | disease | 0.65 |
| Cancer | implicated_in | disease | 0.65 |
| Cardiovascular | implicated_in | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Diabetes | activates | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Als | implicated_in | disease | 0.65 |
| Apoptosis | inhibits | pathway | 0.60 |
| Differentiation | inhibits | pathway | 0.60 |
| Insulin | activates | protein | 0.60 |
| DNA | activates | gene | 0.60 |
| ROS | activates | gene | 0.60 |
| mitochondrial function | participates_in | pathway | 0.60 |
| stem cells | expressed_in | cell_type | 0.60 |
| AKT | associated_with | gene | 0.60 |
| AKT3 | associated_with | gene | 0.60 |
| Pi3K/Akt | inhibits | pathway | 0.60 |
| VEGF | activates | gene | 0.60 |
| VEGF | regulates | gene | 0.60 |
| LC3 | activates | gene | 0.60 |
| VEGF | inhibits | gene | 0.60 |
| VEGF | associated_with | gene | 0.60 |
| SIRT5 | inhibits | gene | 0.60 |
| SIRT5 | associated_with | gene | 0.60 |
| TFEB | associated_with | gene | 0.60 |
| SIRT5 | activates | gene | 0.60 |
| CFH | activates | gene | 0.60 |
| TFEB | targets | gene | 0.60 |
| APOPTOSIS | regulates | gene | 0.60 |
| Apoptosis | regulates | pathway | 0.60 |
| Mitophagy | regulates | pathway | 0.60 |
| Akt | regulates | pathway | 0.60 |
| CANCER | implicated_in | gene | 0.60 |
| AND | activates | gene | 0.60 |
| ALZHEIMER'S DISEASE | activates | gene | 0.60 |
| DIABETES MELLITUS | activates | gene | 0.60 |
| INS | regulates | gene | 0.60 |
| lipid metabolism | participates_in | pathway | 0.60 |
| SIRT5 | targets | gene | 0.60 |
| AKT1 | associated_with | gene | 0.60 |
| UBIQUITIN | activates | gene | 0.60 |
| MUL1 | regulates | gene | 0.60 |
| Phagocytosis | regulates | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| IRS2 | activates | gene | 0.90 |
| AKT1 | associated_with | gene | 0.60 |
| CFH | activates | gene | 0.60 |
| APP | activates | gene | 0.60 |
| MITOPHAGY | regulates | gene | 0.60 |
| AGING | associated_with | gene | 0.60 |
| PHAGOCYTOSIS | activates | gene | 0.60 |
| AKT3 | associated_with | gene | 0.60 |
| AKT | associated_with | gene | 0.60 |
| PI3K | regulates | gene | 0.60 |
| MTOR | regulates | gene | 0.60 |
| MIRNAS | regulates | gene | 0.60 |
| APOPTOSIS | inhibits | gene | 0.60 |
| APP/PS1 | activates | gene | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning AKT2 in their description or question text
No additional research found